Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688050's FCF Margin % is ranked better than 82.7% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs SHSE:688050: 14.07
Eyebright Medical Technology (Beijing) Co FCF Margin % Related Terms
Eyebright Medical Technology (Beijing) Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eyebright Medical Technology (Beijing) Co FCF Margin % Chart
Eyebright Medical Technology (Beijing) Co Annual Data
SHSE:688050 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Eyebright Medical Technology (Beijing) Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eyebright Medical Technology (Beijing) Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eyebright Medical Technology (Beijing) Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Eyebright Medical Technology (Beijing) Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eyebright Medical Technology (Beijing) Co (SHSE:688050) has a FCF Margin % of -3.19% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. According to the industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #141 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 17.3%.
Is Eyebright Medical Technology (Beijing) Co's FCF Margin % too high?
Eyebright Medical Technology (Beijing) Co's current FCF Margin % is -3.19%. Based on the distribution chart, Eyebright Medical Technology (Beijing) Co ranks #141 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Eyebright Medical Technology (Beijing) Co has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Eyebright Medical Technology (Beijing) Co's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Eyebright Medical Technology (Beijing) Co ranks #141 out of 815 companies for FCF Margin %. This places Eyebright Medical Technology (Beijing) Co in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Eyebright Medical Technology (Beijing) Co and its competitors. Eyebright Medical Technology (Beijing) Co's current FCF Margin % is -3.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eyebright Medical Technology (Beijing) Co stock overvalued right now?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co (SHSE:688050) is currently considered Possible Value Trap. The stock's GF Value™ is ¥112.14, compared to a current price of ¥41.49 — trading 63% below its estimated fair value. The current FCF Margin % is -3.19%. Eyebright Medical Technology (Beijing) Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Eyebright Medical Technology (Beijing) Co (SHSE:688050), the current FCF Margin % is -3.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eyebright Medical Technology (Beijing) Co (SHSE:688050) Overvalued in 2026?
Based on GuruFocus' analysis, Eyebright Medical Technology (Beijing) Co stock appears to be undervalued.
The current stock price of ¥41.49 is trading 63% below its estimated GF Value™ of ¥112.14.
GuruFocus considers Eyebright Medical Technology (Beijing) Co to be Possible Value Trap.
Key valuation signals for SHSE:688050:
FCF Margin %: -3.19%
GF Value™: ¥112.14 vs. price of ¥41.49 (63% below fair value)
No single metric tells the full story. See the SHSE:688050 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eyebright Medical Technology (Beijing) Co Business Description
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
74GF Score
Get the complete analysis for SHSE:688050
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688050 has been successfully added to your 
